TY - JOUR T1 - The Assessment of Disease Activity in Psoriatic Arthritis: MDA, VLDA, DAPSA, or Something Else? JF - The Journal of Rheumatology JO - J Rheumatol SP - 663 LP - 664 DO - 10.3899/jrheum.181313 VL - 46 IS - 7 AU - ENNIO LUBRANO Y1 - 2019/07/01 UR - http://www.jrheum.org/content/46/7/663.abstract N2 - Psoriatic arthritis (PsA) is a multifaceted disease. Within this definition, rheumatologists can every day face various aspects of the disease and try to deal with them by choosing the right treatment. This could be a very easy task when some phenotypic manifestations and detectable, objective disease activity are present, but sometimes the same disease could be very challenging when some manifestations such as pain, fatigue, or even enthesitis are predominant and associated with less detectable disease activity.Therefore, in the last decade, a significant effort has been made to identify potential instruments for the assessment of the disease activity as a “whole” and as the main target to be treated. In fact, rheumatologists have raised the bar, moving (as target to treat) from the achievement of good control of single domains such as pain, function, inflammation, skin, and quality of life to a more comprehensive disease control of PsA, aimed at managing the disease in all its components.Indeed, the idea of developing a potential instrument to measure all disease domains was absolutely remarkable, and various ones were eventually developed and validated.Minimal disease activity (MDA)1, very low disease activity (VLDA)2, and the Disease … Address correspondence to Dr. E. Lubrano, University of Molise, Academic Rheumatology Unit, Department of Medicine and Health Sciences, Via Giovanni Paolo II, 86100 Campobasso, Italy. E-mail: enniolubrano{at}hotmail.com ER -